In this context, we hypothesized that, in at-risk individuals, NR3C1 peripheral expression may explain some of the risk of psychosis, independently of cortisol levels, and adjusted by sex, age, cannabis and antipsychotic medication intake. The gene discussed is NR3C1; the disease is psychotic disorder.